SPINEWAY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6462 EUR | +5.93% |
|
+20.79% | -90.50% |
| Apr. 17 | Spineway: punished despite a solid first quarter | CF |
| Apr. 16 | Spineway SA Announces Revenue Results for the First Quarter of 2024 | CI |
| Sales 2022 | 8.53M 9.26M | Sales 2023 | 11.36M 12.33M | Capitalization | 508K 552K |
|---|---|---|---|---|---|
| Net income 2022 | -3M -3.26M | Net income 2023 | -6M -6.51M | EV / Sales 2022 | - |
| Net cash position 2022 | 4.08M 4.43M | Net Debt 2023 | 814K 884K | EV / Sales 2023 | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | 54 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 2.55% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | +5.93% | ||
| 1 week | +20.79% | ||
| Current month | -13.26% | ||
| 1 month | -24.42% | ||
| 3 months | -63.07% | ||
| 6 months | -97.85% | ||
| Current year | -90.50% |
1 week
0.53
0.77
1 month
0.500.89
Current year
0.5030.00
1 year
0.501 760.00
3 years
0.50152 000.00
5 years
0.501 000 000.00
10 years
0.501 000 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 05-09-27 |
| Director of Finance/CFO | - | 20-01-26 | |
Sandrine Carle
PRN | Corporate Officer/Principal | - | Nov. 06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Weiguang Guo
BRD | Director/Board Member | 68 | - |
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 05-09-27 |
Joseph Brigneaud
BRD | Director/Board Member | 46 | 17-10-12 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 0.6462 | +5.93% | 28,462 |
| 24-05-27 | 0.61 | -2.09% | 32,315 |
| 24-05-24 | 0.623 | -4.15% | 32,569 |
| 24-05-23 | 0.65 | -4.34% | 107,225 |
| 24-05-22 | 0.6795 | +22.21% | 91,399 |
Real-time Euronext Paris, May 28, 2024 at 11:17 am EDT
More quotes
Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc.
Net sales are distributed geographically as follows: France (27.8%), Europe (21.4%), Latin America (29.8%), Asia (16.1%) and the Middle East and Africa (4.9%).
Calendar
2024-07-16
- Q2 2024 Sales and Revenue Release
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6462
EUR
Average target price
1.8
EUR
Spread / Average Target
+178.55%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -90.50% | 552K | |
| -7.38% | 181B | |
| -0.46% | 108B | |
| -6.98% | 66.12B | |
| +2.65% | 50.65B | |
| +5.27% | 43.11B | |
| +3.49% | 40.74B | |
| +19.92% | 31.6B | |
| +16.38% | 25.56B | |
| -7.00% | 24.16B |
- Stock Market
- Equities
- ALSPW Stock
